Ellen Rohde
Corporate Officer/Principal en VERVE THERAPEUTICS, INC. .
Cargos activos de Ellen Rohde
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VERVE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2019 | - |
Historial de carrera de Ellen Rohde
Antiguos cargos conocidos de Ellen Rohde.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
| BIOGEN INC. | Corporate Officer/Principal | - | - |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Formación de Ellen Rohde.
| University of Cincinnati (Ohio) | Doctorate Degree |
| Universität Leipzig | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Alemania | 2 |
Operativa
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Ellen Rohde
- Experiencia
